168 related articles for article (PubMed ID: 6527535)
1. Estrogen metabolism in rat liver microsomal and isolated hepatocyte preparations--II. Inhibition studies.
Brueggemeier RW; Kimball JG; Kraft F
J Steroid Biochem; 1984 Dec; 21(6):709-16. PubMed ID: 6527535
[TBL] [Abstract][Full Text] [Related]
2. Estrogen metabolism in rat liver microsomal and isolated hepatocyte preparations--I. Metabolite formation and irreversible binding to cellular macromolecules.
Brueggemeier RW; Kimball JG; Kraft F
Biochem Pharmacol; 1984 Dec; 33(23):3853-9. PubMed ID: 6508837
[TBL] [Abstract][Full Text] [Related]
3. Estrogen 1,2-epoxides or estrogen quinones/semiquinones.
Abul-Hajj YJ
Biochem Biophys Res Commun; 1985 Dec; 133(3):1078-85. PubMed ID: 3002362
[TBL] [Abstract][Full Text] [Related]
4. Estrogen metabolism in microsomal, cell, and tissue preparations of kidney and liver from Syrian hamsters.
Beleh MA; Lin YC; Brueggemeier RW
J Steroid Biochem Mol Biol; 1995 May; 52(5):479-89. PubMed ID: 7748813
[TBL] [Abstract][Full Text] [Related]
5. Covalent binding of estrogen metabolites to hamster liver microsomal proteins: inhibition by ascorbic acid and catechol-O-methyl transferase.
Haaf H; Li SA; Li JJ
Carcinogenesis; 1987 Feb; 8(2):209-15. PubMed ID: 3802402
[TBL] [Abstract][Full Text] [Related]
6. 17 beta-Estradiol metabolism by hamster hepatic microsomes. Implications for the catechol-O-methyl transferase-mediated detoxication of catechol estrogens.
Butterworth M; Lau SS; Monks TJ
Drug Metab Dispos; 1996 May; 24(5):588-94. PubMed ID: 8723741
[TBL] [Abstract][Full Text] [Related]
7. 17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.
Butterworth M; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Jun; 9(4):793-9. PubMed ID: 8831825
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rat liver microsomal estrogen 2-hydroxylase by 2-methoxyestrogens.
Brueggemeier RW; Singh U
J Steroid Biochem; 1989 Oct; 33(4A):589-93. PubMed ID: 2811369
[TBL] [Abstract][Full Text] [Related]
9. Androgens inhibit the formation of catechol estrogens by estrogen 2-hydroxylase present in rat liver microsomal preparations.
Brueggemeier RW; Bannan RA
J Steroid Biochem; 1986 Sep; 25(3):351-4. PubMed ID: 3022073
[TBL] [Abstract][Full Text] [Related]
10. NADPH-dependent formation of polar and nonpolar estrogen metabolites following incubations of 17 beta-estradiol with human liver microsomes.
Lee AJ; Zhu BT
Drug Metab Dispos; 2004 Aug; 32(8):876-83. PubMed ID: 15258114
[TBL] [Abstract][Full Text] [Related]
11. Catechol estrogen formation in MCF-7 cell culture and effects of bromoestrogen inhibitors.
Brueggemeier RW; Katlic NE; Palmer CW; Stevens JM
Mol Cell Endocrinol; 1989 Jul; 64(2):161-7. PubMed ID: 2551756
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of inhibition of estrogen 2-hydroxylase by various haloestrogens.
Brueggemeier RW; Kimball JG
Steroids; 1983 Jul; 42(1):93-103. PubMed ID: 6673180
[TBL] [Abstract][Full Text] [Related]
13. Drug protein conjugates--III. Inhibition of the irreversible binding of ethinylestradiol to rat liver microsomal protein by mixed-function oxidase inhibitors, ascorbic acid and thiols.
Maggs JL; Grabowski PS; Park BK
J Steroid Biochem; 1983 Sep; 19(3):1273-8. PubMed ID: 6621036
[TBL] [Abstract][Full Text] [Related]
14. Estrogen metabolism in primary kidney cell cultures from Syrian hamsters.
Brueggemeier RW; Tseng K; Katlic NE; Beleh MA; Lin YC
J Steroid Biochem; 1990 Jul; 36(4):325-31. PubMed ID: 2391962
[TBL] [Abstract][Full Text] [Related]
15. Activation and irreversible binding of regiospecifically labeled catechol estrogen by rat liver microsomes: evidence for differential cytochrome P-450 catalyzed oxidations.
Jellinck PH; Fishman J
Biochemistry; 1988 Aug; 27(16):6111-6. PubMed ID: 2847784
[TBL] [Abstract][Full Text] [Related]
16. Irreversible binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinase.
Bolt HM; Kappus H
J Steroid Biochem; 1974 Apr; 5(2):179-84. PubMed ID: 4210249
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic treatment with thyroxine and estradiol on estrogen concentration in serum and on hepatic microsomal catechol estrogen formation in female rats.
Shiverick KT; Delorme AM; Scammell JG; Fregly MJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):564-9. PubMed ID: 7086671
[TBL] [Abstract][Full Text] [Related]
18. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
[TBL] [Abstract][Full Text] [Related]
19. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
Chauret N; Nicoll-Griffith D; Friesen R; Li C; Trimble L; Dubé D; Fortin R; Girard Y; Yergey J
Drug Metab Dispos; 1995 Dec; 23(12):1325-34. PubMed ID: 8689939
[TBL] [Abstract][Full Text] [Related]
20. Human fetal liver estrogen 16 alpha-hydroxylase: precursor specificity, kinetic parameters, and in vitro regulation.
Milewich L; MacDonald PC; Guerami A; Midgett WT; Lassiter WL; Carr BR
J Clin Endocrinol Metab; 1986 Jul; 63(1):180-91. PubMed ID: 3711258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
